ChromaDex Corporation

General ticker "CDXC" information:

  • Sector: Health Care
  • Industry: Life Sciences Tools & Services
  • Capitalization: $357.0M (TTM average)

ChromaDex Corporation follows the US Stock Market performance with the rate: 46.1%.

Estimated limits based on current volatility of 4.8%: low 5.59$, high 6.15$

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.58$, 8.73$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.64$, 7.22$]

Financial Metrics affecting the CDXC estimates:

  • Negative: Non-GAAP EPS, $ of 0.04 <= 0.04
  • Negative: Industry operating cash flow per share per price (median), % of 0.98 <= 2.82
  • Negative: Shareholder equity ratio, % of 67.51 > 63.75
  • Positive: 8.37 < Operating profit margin, % of 12.55
  • Negative: negative Industry operating income (median)

Similar symbols

Short-term CDXC quotes

Long-term CDXC plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $72.05MM $83.57MM $61.59MM
Operating Expenses $90.68MM $89.17MM $53.86MM
Operating Income $-18.63MM $-5.60MM $7.73MM
Non-Operating Income $2.09MM $0.66MM $1.13MM
R&D Expense $4.83MM $4.96MM $6.02MM
Income(Loss) $-16.54MM $-4.94MM $8.86MM
Taxes $0.00MM $0.00MM $0.30MM
Profit(Loss)* $-14.45MM $-4.94MM $8.55MM
Stockholders Equity $28.67MM $28.46MM $46.09MM
Inventory $14.68MM $14.53MM $9.19MM
Assets $54.06MM $54.96MM $68.28MM
Operating Cash Flow $-15.10MM $7.12MM $12.11MM
Capital expenditure $0.33MM $0.15MM $0.16MM
Investing Cash Flow $-0.33MM $-0.14MM $-0.14MM
Financing Cash Flow $7.65MM $-0.09MM $5.37MM
Earnings Per Share** $-0.21 $-0.07 $0.11

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.